J&J expects vaccine approval in US 'within a month'
Published
Johnson & Johnson Chief Scientific Officer Paul Stoffels said Friday the vaccine developed by the pharmaceutical company could be approved in the U.S. "within a month.'' (Jan. 29)
Published
Johnson & Johnson Chief Scientific Officer Paul Stoffels said Friday the vaccine developed by the pharmaceutical company could be approved in the U.S. "within a month.'' (Jan. 29)
BERLIN (AP) — Germany’s health minister says he expects the European Union's drug regulator to authorize a further coronavirus..
The promise of widespread vaccination is still out of reach for most Americans. A month after the country’s first vaccinations,..